Early Prediction of Hypoxic-Ischemic Brain Injury by a New Panel of Biomarkers in a Population of Term Newborns

الملخص EN

This research paper is aimed at evaluating the predictive role of a default panel of oxidative stress (OS) biomarkers for the early identification of infants at high risk of HIE and their validation through the correlation with MRI findings.

A multicenter prospective observational study was performed between March 2012 and April 2015 in two European tertiary NICUs.

Eighty-four term infants at risk for HIE (pH < 7, BE < −13 mmol/L, and 5′ Apgar < 5) were enrolled.

Three were excluded for chromosomal abnormalities and one due to lack of blood samples.

The final population was divided according to the severity of perinatal hypoxia into 2 groups: mild/moderate HIE and severe HIE.

Advanced oxidation protein products (AOPP), non-protein-bound iron (NPBI), and F2-isoprostanes (F2-IsoPs) were measured in blood samples at P1 (4–6 hours), P2 (24–72 hours), and P3 (5 days), in both groups.

MRIs were scored for the severity of brain injury, using a modified Barkovich score.

The mean GA was 39.8 weeks (SD 1.4) and the mean birth weight 3538 grams (SD 660); 37 were females and 43 males.

Significantly lower 5′ Apgar score, pH, and BE and higher Thompson score were found in group II compared to group I at birth.

Group II showed significantly higher AOPP and NPBI levels than group I (mean (SD) AOPP: 15.7 (15.5) versus 34.1 (39.2), p=0.033; NPBI 1.1 (2.5) versus 3.9 (4.4), p=0.013) soon after birth (P1).

No differences were observed in OS biomarker levels between the two groups at P2 and P3.

A regression model, including adjustment for hypothermia treatment, gender, and time after birth, showed that AOPP levels and male gender were both risk factors for higher brain damage scores (AOPP: OR 3.6, 95% CI (1.1–12.2) and gender: OR 5.6, 95% CI (1.2–25.7), resp.).

Newborns with severe asphyxia showed higher OS than those with mild asphyxia at birth.

AOPP are significantly associated with the severity of brain injury assessed by MRI, especially in males.